Dalhousie University Halifax, Nova Scotia, Canada
Bagnall AM, Lewis RA, Leitner ML, et al. Ziprasidone for schizophrenia and severe mental illness. Cochrane Review, latest version 27 Oct 1999. Oxford: Update Software.
Source of funding: National Health Service Research & Development Health Technology Assessment Programme, UK.
For correspondence: Dr A M Bagnall, NHS Centre for Reviews and Dissemination, University of York, North Yorkshire YO10 5DD, UK. Fax +44 (0)1904 433661.
